NuVasive has settled a patent dispute with Orthofix and The Musculoskeletal Transplant Foundation, which includes a $2 million payment from Orthofix to cover the settlement, according to a Bloomberg Businessweek report.
NuVasive filed the lawsuit against Orthofix and the foundation in April, claiming the Orthofix's Trinity Evolution infringed on property owned by NuVasive. The complete terms of the settlement were undisclosed.
Read the Bloomberg Businessweek report on the patent infringement.
Read other coverage on NuVasive:
- NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical
- NuVasive Reports 2Q Revenue Up 35.2%
NuVasive filed the lawsuit against Orthofix and the foundation in April, claiming the Orthofix's Trinity Evolution infringed on property owned by NuVasive. The complete terms of the settlement were undisclosed.
Read the Bloomberg Businessweek report on the patent infringement.
Read other coverage on NuVasive:
- NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical
- NuVasive Reports 2Q Revenue Up 35.2%